| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance
|
Hult, Sara
|
|
|
43 |
8 |
p. 775-785
|
artikel
|
| 2 |
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
|
Sultana, Janet
|
|
|
43 |
8 |
p. 691-698
|
artikel
|
| 3 |
Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
|
Härmark, Linda
|
|
|
43 |
8 |
p. 745-749
|
artikel
|
| 4 |
Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
|
Härmark, Linda
|
|
|
43 |
8 |
p. 823
|
artikel
|
| 5 |
Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
|
Patek, Taylor M.
|
|
|
43 |
8 |
p. 825
|
artikel
|
| 6 |
Correction to: Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study
|
de Vries, Sieta T.
|
|
|
43 |
8 |
p. 827-829
|
artikel
|
| 7 |
Critical Assessment of Pharmacokinetic Drug–Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis Treatment
|
Veeravalli, Vijayabhaskar
|
|
|
43 |
8 |
p. 711-725
|
artikel
|
| 8 |
Detecting Medicine Safety Signals Using Prescription Sequence Symmetry Analysis of a National Prescribing Data Set
|
King, Clare E.
|
|
|
43 |
8 |
p. 787-795
|
artikel
|
| 9 |
DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus
|
Pariente, Antoine
|
|
|
43 |
8 |
p. 767-774
|
artikel
|
| 10 |
Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical Studies
|
Cicero, Arrigo F. G.
|
|
|
43 |
8 |
p. 727-736
|
artikel
|
| 11 |
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
|
Osborne, Vicki
|
|
|
43 |
8 |
p. 809-821
|
artikel
|
| 12 |
Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case–Control Study
|
Mazereeuw, Graham
|
|
|
43 |
8 |
p. 737-743
|
artikel
|
| 13 |
Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project
|
Gattepaille, Lucie M.
|
|
|
43 |
8 |
p. 797-808
|
artikel
|
| 14 |
Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme
|
Cheng, Karen
|
|
|
43 |
8 |
p. 751-766
|
artikel
|
| 15 |
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
|
Tuccori, Marco
|
|
|
43 |
8 |
p. 699-709
|
artikel
|
Tijdschrift beschrijving